| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2008 | EP1966133A2 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 09/10/2008 | EP1966132A2 Compounds which modulate the cb2 receptor |
| 09/10/2008 | EP1966131A1 Inhibitors of ccr9 activity |
| 09/10/2008 | EP1966130A2 Modified lysine-mimetic compounds |
| 09/10/2008 | EP1966129A2 Carbonates of fenicol antibiotics |
| 09/10/2008 | EP1965872A2 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof |
| 09/10/2008 | EP1965865A2 Combination of an iap-inhibitor and a taxane7 |
| 09/10/2008 | EP1965864A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 09/10/2008 | EP1965863A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 09/10/2008 | EP1965832A1 Gastrointestinal function promoter |
| 09/10/2008 | EP1965822A2 Ginger extract for inhibiting human drug transporters |
| 09/10/2008 | EP1965821A2 Ginger fraction for inhibiting human cyp enzymes |
| 09/10/2008 | EP1965818A1 Methods for wound healing |
| 09/10/2008 | EP1965809A2 Novel compositions to improve gut health and animal performance and methods of making the same |
| 09/10/2008 | EP1965808A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof |
| 09/10/2008 | EP1965807A2 S1p receptor modulating compounds and use thereof |
| 09/10/2008 | EP1965806A2 Compositions and methods for the treatment and prevention of disease |
| 09/10/2008 | EP1965805A1 Urea derivatives useful as calcium receptor modulators |
| 09/10/2008 | EP1965804A2 Lyophilized compositions of a triazolopyrimidine compound |
| 09/10/2008 | EP1965803A1 Methods and compositions for the treatment of disease |
| 09/10/2008 | EP1965802A2 Pharmaceutical combinations comprising testosterone in the treatment of female sexual dysfunction |
| 09/10/2008 | EP1965801A2 Combination of azd2171 and pemetrexed |
| 09/10/2008 | EP1965800A2 Incontinence treatment methods |
| 09/10/2008 | EP1965799A2 Substituted piperidines as calcium channel blockers |
| 09/10/2008 | EP1965798A2 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 09/10/2008 | EP1965797A1 Methods of reducing adverse events associated with pirfenidone therapy |
| 09/10/2008 | EP1965796A2 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions |
| 09/10/2008 | EP1965795A2 Metaxalone formulations and methods for the preparation thereof |
| 09/10/2008 | EP1965794A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 09/10/2008 | EP1965793A1 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 09/10/2008 | EP1965792A2 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases |
| 09/10/2008 | EP1965791A1 Novel compositions against alkyl-acyl-gpc, the derivatives and products thereof |
| 09/10/2008 | EP1965790A2 Metabolites of wortmannin analogs and methods of using the same |
| 09/10/2008 | EP1965789A2 Combination of a 5-ht4 agonist with a cholinesterase inhibitor |
| 09/10/2008 | EP1965788A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 09/10/2008 | EP1965787A2 Treatment of xerostomia with a sulfur-containing antioxidant |
| 09/10/2008 | EP1965786A2 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof |
| 09/10/2008 | EP1965785A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 09/10/2008 | EP1965784A1 Combination comprising combretastatin and anticancer agents |
| 09/10/2008 | EP1965783A1 Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione |
| 09/10/2008 | EP1965782A1 Use of aminoalcohol derivatives for the treatment of overactive bladder |
| 09/10/2008 | EP1965781A1 Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
| 09/10/2008 | EP1965780A2 Substituted phenol derivatives as analgesics |
| 09/10/2008 | EP1965779A1 Compositions and methods of sensitizing methicillin resistantstaphylococcus aureus to oxacillin |
| 09/10/2008 | EP1965778A2 Novel uses for drugs targeting glutamine synthetase |
| 09/10/2008 | EP1965777A1 Transdermal tobacco alkaloid patch |
| 09/10/2008 | EP1965776A1 Low flexural strength transdermal tobacco alkaloid patch |
| 09/10/2008 | EP1965774A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 09/10/2008 | EP1965773A1 Oral formulation of anhydrous olanzapine form i |
| 09/10/2008 | EP1965770A2 Oral formulations comprising tigecycline |
| 09/10/2008 | EP1965768A2 Fexofenadine suspension formulation |
| 09/10/2008 | EP1965767A2 Pharmaceutical product comprising porous silicon |
| 09/10/2008 | EP1965764A2 Self-emulsifying formulations of cetp inhibitors |
| 09/10/2008 | EP1965762A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 09/10/2008 | EP1965749A1 Testosterone stabilisation in transdermal devices |
| 09/10/2008 | EP1965669A1 Use of soluble dietary fibres against muscle wasting |
| 09/10/2008 | EP1965650A2 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 09/10/2008 | EP1965647A2 Process for manufacturing picolinate borinic esters |
| 09/10/2008 | EP1861130B1 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 09/10/2008 | EP1855692A4 Composition for reducing the exudation of serum proteins |
| 09/10/2008 | EP1828216B1 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 09/10/2008 | EP1771181B1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 09/10/2008 | EP1735308B1 Fused ring azadecalin glucocorticoid receptor modulators |
| 09/10/2008 | EP1729797B1 Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| 09/10/2008 | EP1729598B1 Composition; use of a composition and a method for preventing fat absorption |
| 09/10/2008 | EP1685107B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 09/10/2008 | EP1658071B1 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors |
| 09/10/2008 | EP1646389B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 09/10/2008 | EP1626715B1 Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
| 09/10/2008 | EP1618875B1 Composition for inhibition or prevention of bone density lowering |
| 09/10/2008 | EP1605954B1 A food-supplement composition suitable for promoting iron absorption |
| 09/10/2008 | EP1597240B1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 09/10/2008 | EP1578415B1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 09/10/2008 | EP1562547B1 Method of stimulating hair growth using benzopyrans |
| 09/10/2008 | EP1558620B1 Ruthenium anticancer complexes |
| 09/10/2008 | EP1551417B1 Three layer tear formulation |
| 09/10/2008 | EP1503741B1 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 09/10/2008 | EP1492531B1 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 09/10/2008 | EP1487903B1 Supercritical fluid extraction of vitreoretinal silicone tamponades |
| 09/10/2008 | EP1486501B1 Aminomethyl-substituted thiazolobenzimidazole derivative |
| 09/10/2008 | EP1480757B1 A fluid dispensing device |
| 09/10/2008 | EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1437349B9 Substituted isoxazoles and the use thereof as antibiotics |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1392375B1 Composition and use of substances for stabilising amino acids containing sulphur |
| 09/10/2008 | EP1373396B1 Highly nucleated thermoplastic articles |
| 09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
| 09/10/2008 | EP1362856B1 Water-soluble triazole fungicide |
| 09/10/2008 | EP1350511B1 Medicinal compositions containing aspirin |
| 09/10/2008 | EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 09/10/2008 | EP1312374B1 Primrose seed extracts as sugar absorption inhibitors and process for producing the same |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | EP1294705B1 Synthesis of cyclic compounds |
| 09/10/2008 | EP1285908B1 Substituted phenylpropionic acid derivatives |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1077691B1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |